Switzerland office
15 Chemin Louis-Dunant

Tel: +41229077715

About DNDi

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases.

See DNDi‘s vision & mission and objectives.

DNDi is working on the following diseases:

Leishmaniasis Icon     Sleeping sickness icon     Chagas disease icon     Paediatric HIV icon

Leishmaniasis  |  Sleeping Sickness  |  Chagas disease  |  Paediatric HIV

Filarial disease icon     Mycetoma icon     Hepatitis C icon     Malaria Icon

Filarial diseases  |  Mycetoma  |  Hepatitis C  |  Malaria

GARDP IconIn 2016, in collaboration with the World Health Organization, DNDi launched the Global Antibiotic Research & Development Partnership (GARDP), a not-for-profit research and development organization to develop new antibiotic treatments addressing antimicrobial resistance and to promote their responsible use for optimal conservation, while ensuring equitable access for all.


39 R&D projects
in 8 disease areas
with 8 treatments delivered


20 entirely new chemical entities (NCEs) in the pipeline



clinical trial platforms
Several technology transfers



210 staff
Half in endemic countries
Close to 1,000 people working on DNDi projects

This recruiter is not currently advertising. Why not try our job search?